Back to Explorer

Use of a Drug Master File for Shared System REMS Submissions Guidance for Industry

DraftCenter for Drug Evaluation and Research Center for Biologics Evaluation and Research11/09/2017

Scope & Applicability

Stakeholders

4
SSR applicant

The party responsible for submitting cross-reference submissions and the LOA.

SSR applicants

Multiple applicants coordinating identical REMS-related documents.

DMF holder

new facilities added by the DMF holder

Applicant

Entity submitting development data and knowledge; Entity performing the work process for change

Regulatory Context

Attributes

1
eCTD format

The required electronic format for DMF submissions.

Related CFR Sections (1)

  • 21CFR314.420§ 314.420 Drug master files.

    (a) A drug master file is a submission of information to the Food and Drug Administration by a person (the drug master file holder) who intends it to be used for one of the following purposes: To permit the holder to incorporate the information by reference when the holder submits an investigationalRead full regulation →

See Also (4)

Use of a Drug Master File for Shared System REMS Submissions Guidance for Industry | Guideline Explorer | BioRegHub